Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Promoting informed decision making about prostate cancer screening.

E C Chan1

  • 1Division of General Internal Medicine, Department of Medicine, University of Texas-Houston Health Science Center, 6431 Fannin, 1.122 MSB, Houston, TX 77030, USA.

Comprehensive Therapy
|September 25, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

G-1-activated membrane estrogen receptors mediate increased contractility of the human myometrium.

Endocrinology·2011
Same author

Reverse haemolytic plaque assay study of corticotropin-releasing hormone and arginine vasopressin interaction in ovine corticotropes.

Journal of neuroendocrinology·2009
Same author

Desensitization of superfused isolated ovine anterior pituitary cells to human corticotropin-releasing factor.

Journal of neuroendocrinology·2009
Same author

Large Molecular Weight Immunoreactive Corticotrophin-Releasing Hormone has Bioactivity on Superfused Ovine Pituitary Cells.

Journal of neuroendocrinology·2009
Same author

Nonhematologic malignancies after allogeneic hematopoietic stem cell transplantation: incidence and molecular monitoring.

Bone marrow transplantation·2004
Same author

Expression patterns of cell cycle and apoptosis-related genes in a multidrug-resistant human colon carcinoma cell line.

Scandinavian journal of gastroenterology·2004

Prostate cancer screening using prostate specific antigen (PSA) is debated. Informed consent, including discussing PSA facts and providing educational materials, is recommended for patients undergoing screening.

Area of Science:

  • Urology
  • Oncology
  • Preventive Medicine

Background:

  • Prostate specific antigen (PSA) screening for prostate cancer remains a controversial topic in clinical practice.
  • The benefits and harms of PSA screening necessitate careful patient consideration.

Purpose of the Study:

  • To emphasize the importance of informed consent in prostate cancer screening.
  • To guide physicians on effectively communicating PSA screening information to patients.

Main Methods:

  • Discussions between physicians and patients regarding PSA screening.
  • Supplementation of discussions with informational brochures and videotapes.

Main Results:

  • Informed consent is a crucial component of the prostate cancer screening process.

Related Experiment Videos

  • Physicians should proactively engage patients in understanding PSA screening facts.

    • Conclusions:

    • Informed consent is essential due to the controversial nature of PSA screening.
    • Utilizing supplementary educational materials can enhance patient understanding and shared decision-making.